Attention Deficit Hyperactivity Disorder and Long-QT Syndrome: Risky Business.

Attention Deficit Hyperactivity Disorder and Long-QT Syndrome: Risky Business.

J Cardiovasc Electrophysiol. 2015 Jun 22;

Authors: Kaltman JR, Berul CI

Abstract
During the past decade, the concern about cardiovascular risks of stimulant medications for the treatment of attention deficit hyperactivity disorder (ADHD) have swung from panicked worry to more reasoned reflection. Recent large epidemiological studies have reassured the scientific, medical, and patient communities that a safety signal does not exist for the occurrence of cardiac events in patients receiving stimulant therapy. In this issue of the Journal, Zhang et al. provide new data on a previously understudied population in this arena, patients with the long-QT syndrome (LQTS).(1) Will the pendulum swing again? This article is protected by copyright. All rights reserved.

PMID: 26102514 [PubMed – as supplied by publisher]

via http://ift.tt/1GpohlI